Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 21;7(3):54.
doi: 10.3390/vision7030054.

Minimally Invasive Glaucoma Surgery: A Review of the Literature

Affiliations
Review

Minimally Invasive Glaucoma Surgery: A Review of the Literature

Michael Balas et al. Vision (Basel). .

Abstract

Minimally invasive glaucoma surgery (MIGS) has emerged as a novel approach in the glaucoma treatment spectrum, offering a range of diverse procedures and devices aimed at reducing intraocular pressure (IOP). MIGS can be broadly classified into several categories: those that enhance trabecular outflow (Trabectome, iStent, Hydrus Microstent, Kahook Dual Blade, high frequency deep sclerotomy, and gonioscopy-assisted transluminal trabeculotomy), those that augment suprachoroidal outflow (CyPass Microstent and iStent Supra), those that target Schlemm's canal (TRAB360 and the OMNI Surgical System, Streamline, and Ab Interno Canaloplasty), and conjunctival bleb-forming procedures (EX-PRESS Glaucoma Filtration Device, Xen Gel Stent and PreserFlo MicroShunt). MIGS is considered to have a shorter surgical time and fewer severe complications when compared to traditional glaucoma surgeries such as trabeculectomy and glaucoma drainage device implantation (Ahmed, Baerveldt, and Molteno valves). This literature review comprehensively examines the distinct MIGS devices and procedures, their underlying mechanisms, and clinical outcomes, emphasizing the importance of evaluating the efficacy and complications of each approach individually. As the field of MIGS continues to evolve, it is crucial to prioritize high-quality, long-term studies to better understand the safety and effectiveness of these innovative interventions in glaucoma management.

Keywords: MIGS; conjunctival bleb-forming procedures; glaucoma; intraocular pressure; literature review; minimally invasive glaucoma surgery; suprachoroidal outflow; surgical advances; trabecular outflow.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Illustration depicting the coronal cross-section of the anterior segment of the eye, highlighting the anatomic localization of each minimally invasive glaucoma surgery (MIGS) device category, including subconjunctival shunts, suprachoroidal outflow, as well as Schlemm’s canal targeted and trabecular outflow devices. ABiC: Ab Interno Canaloplasty; GATT: gonioscopy-assisted transluminal trabeculotomy; HDFS: high-frequency deep sclerotomy.

References

    1. Lavia C., Dallorto L., Maule M., Ceccarelli M., Fea A.M. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS ONE. 2017;12:e0183142. doi: 10.1371/journal.pone.0183142. - DOI - PMC - PubMed
    1. SooHoo J.R., Seibold L.K., Radcliffe N.M., Kahook M.Y. Minimally invasive glaucoma surgery: Current implants and future innovations. Can. J. Ophthalmol. 2014;49:528–533. doi: 10.1016/j.jcjo.2014.09.002. - DOI - PubMed
    1. Mathew D.J., Buys Y.M. Minimally invasive glaucoma surgery: A critical appraisal of the literature. Annu. Rev. Vis. Sci. 2020;6:47–89. doi: 10.1146/annurev-vision-121219-081737. - DOI - PubMed
    1. Conlon R., Saheb H., Ahmed I.I.K. Glaucoma treatment trends: A review. Can. J. Ophthalmol. 2017;52:114–124. doi: 10.1016/j.jcjo.2016.07.013. - DOI - PubMed
    1. Ahmed I.I.K. MIGS and the FDA: What’s in a Name? Ophthalmology. 2015;122:1737–1739. doi: 10.1016/j.ophtha.2015.06.022. - DOI - PubMed